Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to -$34000.0.

  • Iridex's Cash from Financing Activities fell 10120.44% to -$34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 10129.01%. This contributed to the annual value of $2.6 million for FY2024, which is 5220000.0% up from last year.
  • Per Iridex's latest filing, its Cash from Financing Activities stood at -$34000.0 for Q3 2025, which was down 10120.44% from -$14000.0 recorded in Q2 2025.
  • In the past 5 years, Iridex's Cash from Financing Activities registered a high of $9.9 million during Q2 2021, and its lowest value of -$218000.0 during Q4 2024.
  • Over the past 5 years, Iridex's median Cash from Financing Activities value was -$4000.0 (recorded in 2022), while the average stood at $1.8 million.
  • Per our database at Business Quant, Iridex's Cash from Financing Activities soared by 49455000.0% in 2021 and then plummeted by 58444.44% in 2024.
  • Over the past 5 years, Iridex's Cash from Financing Activities (Quarter) stood at $9.9 million in 2021, then crashed by 100.26% to -$26000.0 in 2022, then surged by 273.08% to $45000.0 in 2023, then tumbled by 584.44% to -$218000.0 in 2024, then skyrocketed by 84.4% to -$34000.0 in 2025.
  • Its Cash from Financing Activities stands at -$34000.0 for Q3 2025, versus -$14000.0 for Q2 2025 and $6.0 million for Q1 2025.